drugset / Trial / NCT00494507
Hyper- and Hypokalemic Periodic Paralysis Study
Phase 3
Completed
71 enrolled
University of Rochester
National Institute of Neurological Disorders and Stroke (NINDS) · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to compare Dichlorphenamide with placebo (an inactive substance) for prevention of episodes and for improvement of strength in hyperkalemic (HYP) and hypokalemic (HOP) periodic paralysis. This study will also look at the long-term effects of Dichlorphenamide in periodic paralysis.
Timeline
- Start
- 2007-06
- Primary completion
- 2013-04
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dichlorphenamide | Small molecule | 50 mg | — |
| Comparator | Dichlorphenamide | Small molecule | 400 mg | — |